Low Incidence of Perioperative Chemotherapy for Stage III Bladder Cancer 1998 to 2003: A Report From the National Cancer Data Base

Journal of Urology

Volumn 178, Issue 2, 2007, Pages 451-454

  David, Kevin A ^a   Milowsky, Matthew I ^a   Ritchey, Jamie ^b   Carroll, Peter R ^c   Nanus, David M ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b AMERICAN COLLEGE OF SURGEONS   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

adjuvant; carcinoma; chemotherapy; neoadjuvant therapy; perioperative care; transitional cell; urinary bladder neoplasms

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER STATISTICS; CANCER SURGERY; CHI SQUARE TEST; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION COEFFICIENT; DATA ANALYSIS; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, TRANSITIONAL CELL; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; CYSTECTOMY; DATABASES, FACTUAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RETROSPECTIVE STUDIES; UNITED STATES; URINARY BLADDER; URINARY BLADDER NEOPLASMS; UTILIZATION REVIEW;

EID: 34447095141     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.03.101     Document Type: Article

References (20)

1. American Cancer Society Facts and Figures 2006 (2006), American Cancer Society, Atlanta
2. Malmstrom P., Rintala E., Wahlqvist R., Hellstrom P., Hellsten S., and Hannisdal E. Five-year followup of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic Cystectomy Trial 1. J Urol 155 (1996) 1903
3. Grossman H.B., Natale R.B., Tangen C.M., Speights V.O., Vogelzang N.J., Trump D.L., et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349 (2003) 859
4. Advanced Bladder Cancer Meta-analysis Collaboration: neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis. Lancet 361 (2003) 1927
5. Winquist E., Kirchner T.S., Segal R., Chin J., and Lukka H. Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: a systematic review and meta-analysis. J Urol 171 (2004) 561
6. Skinner D.G., Daniels J.R., Russell C.A., Lieskovsky G., Boyd S.D., Nichols P., et al. The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. J Urol 145 (1991) 459
7. Stockle M., Meyenburg W., Wellek S., Voges G., Gertenbach U., Thuroff J.W., et al. Advanced bladder cancer (stages pT3b, pT4a, pN1, and pN2): improved survival after radical cystectomy and 3 adjuvant cycles of chemotherapy. Results of a controlled prospective study. J Urol 148 (1992) 302
8. Freiha F., Reese J., and Torti F.M. A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer. J Urol 155 (1996) 495
9. Ruggeri E.M., Giannarelli D., Bria E., Carlini P., Felici A., Nelli F., et al. Adjuvant chemotherapy in muscle-invasive bladder carcinoma. Cancer 106 (2006) 783
10. Cancer Facts and Figures 1998-2002. Atlanta: American Cancer Society.
11. International Classification of Diseases for Oncology. 3rd ed. (2000), World Health Organization, Lyon
12. Greene F.L., Page D.L., Fleming I.D., Fritz A., Balch C.M., Haller D.G., et al. AJCC Cancer Staging Manual. 6th ed. (2002), Springer Verlag, New York
13. Fleming I.D., Cooper J.S., and Henson D.E. AJCC Cancer Staging Manual (1997), Lippincott-Raven, Philadelphia
14. Facility Oncology Registry Data Standards: Revised for 2004 (2004), American College of Surgeons, Chicago
15. Registry Operations and Data Standards (1998), American College of Surgeons, Chicago
16. Schrag D., Mitra N., Xu F., Rabbani F., Bach P.B., Herr H., et al. Cystectomy for muscle-invasive bladder cancer: patterns and outcomes of care in the Medicare population. Urology 65 (2005) 1118
17. Snyder C., Harlan L., Knopf K., Potosky A., and Kaplan R. Patterns of care for the treatment of bladder cancer. J Urol 169 (2003) 1697
18. Matsui Y., Nishiyama H., Watanabe J., Teramukai S., Ono Y., Ohshima S., et al. The current status of perioperative chemotherapy for invasive bladder cancer: a multiinstitutional retrospective study in Japan. Int J Clin Oncol 10 (2005) 133
19. Scrimger R.A., Murtha A.D., Parliament M.B., Venner P.M., Hanson J., Houle G., et al. Muscle-invasive transitional cell carcinoma of the urinary bladder: a population-based study of patterns of care and prognostic factors. Int J Radiat Oncol Biol Phys 51 (2001) 23
20. Chung D., Hersey K., and Fleshner N. Differences between urologists in United States and Canada in approach to bladder cancer. Urology 65 (2005) 919